Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
114,162,973
-
Share change
-
-4,263,222
-
Total reported value
-
$32,365,653,378
-
Put/Call ratio
-
123%
-
Price per share
-
$283.68
-
Number of holders
-
1,028
-
Value change
-
-$1,194,834,405
-
Number of buys
-
383
-
Number of sells
-
504
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q3 2020
As of 30 Sep 2020,
BIOGEN INC. - COM (BIIB) was held by
1,028 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
114,162,973 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Clearbridge Investments, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Bank of New York Mellon Corp, and AQR CAPITAL MANAGEMENT LLC.
This page lists
1,033
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.